Sask. vaccine developer locks in Canadian manufacturers for human clinical trials

CBC.ca

29 Jul 2020 0 shares 1 views

Sask. vaccine developer locks in Canadian manufacturers for human clinical trials

CBC.ca

Published 29 Jul 2020

The University of Saskatchewan has contracted two Canadian pharmaceutical companies to manufacture ingredients for its COVID-19 vaccine for the first stages of human clinical trials.

Full Article

Which Canadians get the COVID-19 vaccine first? Experts have to decide

When scientists predict that a COVID-19 vaccine could be approved as soon as the new year, they raise an alluring prospect: An..

National Post 23 Jul 2020

Proactive news headlines: Power Metal, Itaconix, Zoetic International, ADM Energy, Scancell Holdings …

Power Metal Resources PLC (LON:POW) hares surged higher on Wednesday after the firm said it has decided to take out an option over..

Proactive Investors 22 Jul 2020

Sask. vaccine developer locks in Canadian manufacturers for human clinical trials

Sask. vaccine developer locks in Canadian manufacturers for human clinical trials

You might like

Related news coverage

Which Canadians get the COVID-19 vaccine first? Experts have to decide

Proactive news headlines: Power Metal, Itaconix, Zoetic International, ADM Energy, Scancell Holdings …

Advertisement